Kyle Smith

Q: What is Kyle Jay Smith email address?

Email Kyle Jay Smith at kylejaysmith@gmail.com, zer0c00l22@msn.com, zer0c00l22@aol.com, kacerelizabeth00@aol.com, zer0c00l@aol.com, zer0c00l22@concentric.net, flipout2@webtv.net and ksmith@argenx.com. This email is the most updated Kyle Jay Smith's email found in 2026.

Q: How to contact Kyle Jay Smith?

To contact Kyle Jay Smith send an email to kylejaysmith@gmail.com, zer0c00l22@msn.com, zer0c00l22@aol.com, kacerelizabeth00@aol.com, zer0c00l@aol.com, zer0c00l22@concentric.net, flipout2@webtv.net or ksmith@argenx.com. (updated on January 09, 2025)

Director - Safety Risk Management (Global Patient Safety and Pharmacovigilance) at argenx | Grand Rapids, Michigan, United States

About Kyle Smith

Kyle Jay Smith, in his current role as Director of Safety Risk Management at argenx, brings over two decades of comprehensive experience in global patient safety, pharmacovigilance, and medical affairs within the pharmaceutical and healthcare sectors. At argenx, he plays a pivotal role in ensuring the safety and well-being of patients by providing expert oversight of pharmacovigilance activities across a diverse portfolio of innovative biologics and targeted therapies. His responsibilities include implementing state-of-the-art safety risk management strategies, conducting rigorous safety signal detection, and performing ongoing review of emerging safety data from sources such as individual case safety reports (ICSRs), published literature, and aggregate safety reports. Kyle’s expertise extends to leading safety signal management activities, including risk assessment, benefit-risk evaluations, and the development of risk minimization plans aligned with global regulatory standards.

With a strong foundation in clinical development and operations, Kyle leverages his skills in Good Clinical Practice (GCP), clinical trials, and healthcare management to ensure compliance and optimize pharmacovigilance processes. His deep understanding of therapeutic areas such as oncology, hematology, and neurology enables him to interpret complex safety data effectively, facilitating proactive risk mitigation strategies. Additionally, Kyle’s proficiency in utilizing advanced pharmacovigilance tools and data analysis platforms supports his ability to identify safety signals early and implement appropriate safety measures. His leadership in cross-functional teams underscores his commitment to maintaining the highest standards of patient safety and regulatory compliance, making him a vital asset in the global pharmacovigilance landscape at argenx.

Kyle Smith Work